Skip to content
Isradipine
Dynacirc (isradipine) is a small molecule pharmaceutical. Isradipine was first approved as Dynacirc on 1990-12-20. It is used to treat hypertension and variant angina pectoris in the USA. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D, voltage-dependent L-type calcium channel subunit alpha-1F, voltage-dependent L-type calcium channel subunit alpha-1S, and voltage-dependent L-type calcium channel subunit alpha-1C.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Isradipine
Tradename
Company
Number
Date
Products
DYNACIRC CRGSKN-020336 DISCN1994-06-01
2 products, RLD
DYNACIRCSmithkline BeechamN-019546 DISCN1990-12-20
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
isradipineANDA2023-06-09
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
hypertensionEFO_0000537D006973I10
variant angina pectorisD000788I20.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
C08: Calcium channel blockers
C08C: Selective calcium channel blockers with mainly vascular effects
C08CA: Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects
C08CA03: Isradipine
HCPCS
No data
Clinical
Clinical Trials
44 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Invasive hydatidiform moleD002820D39.211
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Invasive fungal infectionsD000072742213
AspergillosisD001228EFO_0007157B4433
Myeloid leukemia acuteD015470C92.0212
CandidemiaD058387EFO_100128211
Invasive candidiasisD058365EFO_1001283B3711
MycosesD009181B35-B4911
Sars-cov-2D00008640211
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Invasive pulmonary aspergillosisD055744B44.0213
MucormycosisD009091EFO_0007380B46.5112
Hematologic neoplasmsD019337112
Myeloproliferative disordersD009196D47.111
Myelodysplastic syndromesD009190D4611
NeutropeniaD009503D7011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients2525
PharmacokineticsD01059933
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameISRADIPINE
INNisradipine
Description
Isradipine is an isopropyl ester, a methyl ester, a dihydropyridine and a benzoxadiazole.
Classification
Small molecule
Drug classphenylpyridine vasodilators; tricyclic compounds
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12
Identifiers
PDB
CAS-ID75695-93-1
RxCUI33910
ChEMBL IDCHEMBL1648
ChEBI ID
PubChem CID3784
DrugBankDB00270
UNII IDYO1UK1S598 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CACNA1D
CACNA1D
CACNA1F
CACNA1F
CACNA1S
CACNA1S
CACNA1C
CACNA1C
Organism
Homo sapiens
Gene name
CACNA1D
Gene synonyms
CACH3, CACN4, CACNL1A2, CCHL1A2
NCBI Gene ID
Protein name
voltage-dependent L-type calcium channel subunit alpha-1D
Protein synonyms
calcium channel, L type, alpha-1 polypeptide, Calcium channel, L type, alpha-1 polypeptide, isoform 2, calcium channel, neuroendocrine/brain-type, alpha 1 subunit, calcium channel, voltage-dependent, L type, alpha 1D subunit, voltage-gated calcium channel alpha 1 subunit, voltage-gated calcium channel alpha subunit Cav1.3, Voltage-gated calcium channel subunit alpha Cav1.3
Uniprot ID
Mouse ortholog
Cacna1d (12289)
voltage-dependent L-type calcium channel subunit alpha-1D (Q99246)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,863 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,366 adverse events reported
View more details